Contribution of copy number to improve risk stratification of adult T-cell acute lymphoblastic leukemia patients enrolled in measurable residual disease-oriented trials

פריטים דומים

• Contribution of copy number to improve risk stratification of adult T-cell acute lymphoblastic leukemia patients enrolled in measurable residual disease-oriented trials
  מאת: Celia Gonzalez-Gil, et al.
  יצא לאור: (2024-08-01)
• Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials
  מאת: Celia González-Gil, et al.
  יצא לאור: (2022-11-01)
• Outcomes of pediatric and adult patients with relapsed/refractory cortical (CD1a+) T-cell acute lymphoblastic leukemia. The Spanish experience from SEHOP and PETHEMA groups
  מאת: Cristina Rivera-Pérez, et al.
  יצא לאור: (2026-03-01)
• Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group
  מאת: Albert Oriol, et al.
  יצא לאור: (2010-04-01)
• High‐risk cytogenetic abnormalities in multiple myeloma: PETHEMA‐GEM experience
  מאת: Veronica González‐Calle, et al.
  יצא לאור: (2024-12-01)